School of Medicine and Public Health, The University of Newcastle Faculty of Health and Medicine, Callaghan, New South Wales, Australia.
Department of Consultation Liaison Psychiatry, John Hunter Hospital, New Lambton, New South Wales, Australia.
BMJ Open. 2020 Oct 10;10(10):e035155. doi: 10.1136/bmjopen-2019-035155.
Procedural anxiety relates to an affective state of anxiety or fear in relation to a medical procedure. Various treatment-related factors may elicit anxiety among oncology patients, including fear of diagnostic imaging (such as MRI scans) and impending treatment and medical procedures (such as chemotherapy and radiotherapy). It is common in oncology settings to manage acute anxiety relating to medical procedures with anxiolytic medication. However, pharmacological approaches are not suitable for many patients. Despite this, non-pharmacological interventions are infrequently used. The aim of this systematic review is to determine whether non-pharmacological interventions delivered prior to, or during, radiotherapy are effective in reducing procedural anxiety.
Data sources will include the bibliographic databases CINAHL, MEDLINE, EMBASE, PsycINFO and Cochrane Central Register of Controlled trials (CENTRAL) (from inception onward). Eligible studies will include adult patients with cancer undergoing radiotherapy treatment. Included studies will be those which employ a non-pharmacological intervention, delivered within existing radiotherapy appointments, with the aim of reducing procedural anxiety related to radiotherapy. All research designs with a control or other comparison group will be included. The primary outcome will be change in levels of self-reported procedural anxiety. Secondary outcomes will be changes in scores on physiological measures of anxiety and/or changes in treatment completion and/or changes in treatment duration and/or changes in psychological distress. Two investigators will independently complete title and abstract screening, full-text screening, data extraction and assessment of methodological quality. If appropriate, a meta-analyses will be performed. Any important amendments to this protocol will be updated in the PROSPERO registration and documented in the resulting review publication.
No ethical issues are anticipated from this review. The findings will be disseminated through peer-reviewed publication and at conferences by presentation.
CRD42019112941.
程序性焦虑与医疗程序相关的焦虑或恐惧的情感状态有关。各种与治疗相关的因素可能会引起肿瘤患者的焦虑,包括对诊断成像(如 MRI 扫描)和即将进行的治疗和医疗程序(如化疗和放疗)的恐惧。在肿瘤学环境中,通常使用抗焦虑药物来管理与医疗程序相关的急性焦虑。然而,药理方法并不适合许多患者。尽管如此,非药物干预措施很少使用。本系统评价的目的是确定在放疗前或放疗期间进行的非药物干预措施是否能有效降低程序性焦虑。
数据来源将包括 CINAHL、MEDLINE、EMBASE、PsycINFO 和 Cochrane 对照试验中心注册库(CENTRAL)(从成立开始)等文献数据库。符合条件的研究将包括接受放疗治疗的癌症成年患者。将纳入的研究包括在现有放疗预约期间进行的非药物干预措施,旨在降低与放疗相关的程序性焦虑。将纳入所有具有对照或其他比较组的研究设计。主要结局将是自我报告的程序性焦虑程度的变化。次要结局将是焦虑的生理测量评分的变化和/或治疗完成率的变化和/或治疗持续时间的变化和/或心理困扰的变化。两名调查员将独立完成标题和摘要筛选、全文筛选、数据提取和方法学质量评估。如果合适,将进行荟萃分析。本方案的任何重要修正案将在 PROSPERO 注册中更新,并在随后的综述出版物中记录。
本综述预计不会出现伦理问题。研究结果将通过同行评议的出版物和会议上的演讲进行传播。
CRD42019112941。